Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 15, 2019

View Archived Issues

ALKBH proteins are potential therapeutic targets in HNSCC

Novel GET zebrafish larvae model of invasive mycoses

GalNAc-siTAZ improves hepatic inflammation, fibrosis and liver damage in models of NASH

Targeting Piezo1 channel as promising new therapeutic strategy in prostate cancer

Reservoir grows when ART starts

Accidental immunity gives rotavirus insight

Ironing out regional differences affects anxiety

Patient enrollment under way in phase I study of FT-516

Matinas BioPharma initiates EnACT study of MAT-2203 for fungal cryptococcal meningitis

Wuhan Institute of Virology describes respiratory syncytial virus vaccine antigen

Novel PSMA-targeting 177-Lu radiolabeled compounds with outstanding tumor uptake presented

Recombinant Clonorchis sinensis heat shock cognate protein B patented by Xuzhou Medical University

Bristol-Myers Squibb identifies new TYK2 inhibitors

Intra-Cellular Therapies discovers 5-HT2A antagonists/mu-opioid receptor partial agonists

DE Shaw Research and Relay Therapeutics disclose PTPN11 inhibitors

Progression-free survival improved with ivosidenib in pivotal cholangiocarcinoma trial

NMSS grant supports Clene's development of nanocatalytic therapeutic CNM-Au8 for MS

Immunotherapy frontiers: 'Strength in numbers', 'it only takes one' both true for neoantigens

Primary endpoint met in registrational MOXIe trial of omaveloxolone for Friedreich's ataxia

Collaborative Medicinal Development enrolls first patient in new study of CuATSM for ALS

Viela Bio enrolling kidney transplant recipients for phase IIa trial of VIB-4920 and belatacept

AstraZeneca initiates first-in-human study of AZD-4041 in healthy volunteers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...